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A B S T R A C T   
Fetal alcohol spectrum disorders (FASD) are a spectrum of developmental disorders caused by prenatal alcohol 
exposure. Neuronal loss or neurodegeneration in the central nervous system (CNS) is one of the most devastating 
features in FASD. It is imperative to delineate the underlying mechanisms to facilitate the treatment of FASD. 
Endoplasmic reticulum (ER) stress is a hallmark and an underlying mechanism of many neurodegenerative 
diseases, including ethanol-induced neurodegeneration. Mesencephalic astrocyte-derived neurotrophic factor 
(MANF) responds to ER stress and has been identified as a protein upregulated in response to ethanol exposure 
during the brain development. To investigate the role of MANF in ethanol-induced neurodegeneration and its 
association with ER stress regulation, we established a CNS-specific Manf knockout mouse model and examined 
the effects of MANF deficiency on ethanol-induced neuronal apoptosis and ER stress using a third-trimester 
equivalent mouse model. We found MANF deficiency exacerbated ethanol-induced neuronal apoptosis and ER 
stress and that blocking ER stress abrogated the harmful effects of MANF deficiency on ethanol-induced neuronal 
apoptosis. Moreover, using an animal model of ER-stress-induced neurodegeneration, we demonstrated that 
MANF deficiency potentiated tunicamycin (TM)-induced ER stress and neurodegeneration. A whole tran-
scriptome RNA sequencing also supported the functionality of MANF in ER stress modulation and revealed 
targets that may mediate the ER stress-buffering capacity of MANF. Collectively, these results suggest that MANF 
is a neurotrophic factor that can protect neurons against ethanol-induced neurodegeneration by ameliorating ER 
stress.   
1. Introduction 
Fetal alcohol spectrum disorders (FASD) represent a spectrum of 
disorders resulted from prenatal alcohol exposure (Lebel et al., 2011; 
Mattson et al., 2013). In the United States, around 2–5% of babies are 
born with FASD each year (May et al., 2018). The CNS development is a 
complex and exquisitely orchestrated process. Developmental exposure 
to alcohol impacts this process, which is manifested by learning and 
memory deficits as well as other neuropathology (Kane and Drew, 2020; 
Mattson et al., 2011). Imaging studies reveal alterations of structure and 
neural circuitry in brain regions like the hippocampus, cerebral cortex, 
and cerebellum (Joseph et al., 2014; Norman et al., 2009). The 
Abbreviations: ATF6, activating transcription factor 6; ARMET, arginine-rich mutated in early stages of tumor; AUD, alcohol use disorder; BBB, blood-brain 
barrier; BEC, blood ethanol concentration; CHOP, CCAAT/enhancer-binding protein homologous protein; CNS, central nervous system; DAMP, damage-associated 
molecular pattern; ER, endoplasmic reticulum; FASD, fetal alcohol spectrum disorders; HMGB1, high mobility group box 1; IRE1, Inositol-requiring kinase; MANF, 
mesencephalic astrocyte-derived neurotrophic factor; NF-κβ, nuclear factor kappa-light-chain-enhancer of activated B cells; 4-PBA, sodium phenylbutyrate; PD, 
postnatal day; PERK, protein kinase RNA-like endoplasmic reticulum kinase; RAGE, receptor for advanced glycation end products; TLR, toll-like receptors; TM, 
tunicamycin; TNFα, tumor necrosis factor-alpha; UPR, unfolded protein response. 
* Corresponding author at: Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, United States of America. 
E-mail address: jia-luo@uiowa.edu (J. Luo).  
Contents lists available at ScienceDirect 
Neurobiology of Disease 
journal homepage: www.elsevier.com/locate/ynbdi 
https://doi.org/10.1016/j.nbd.2020.105216 
Received 15 September 2020; Received in revised form 18 November 2020; Accepted 3 December 2020   
Downloaded for Anonymous User (n/a) at University of Kentucky from ClinicalKey.com by Elsevier on December 19, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
Neurobiology of Disease 148 (2021) 105216
2
structural changes in the hippocampus and cerebrum are correlated with 
the severity of cognitive dysfunction, whereas damages to the cere-
bellum are associated with motor dysfunction and cerebellar-linked 
cognitive deficits (Connor et al., 2006; Diwadkar et al., 2013; Glass 
et al., 2014). The effects of structural damage on the CNS are long- 
lasting; individuals with FASD are more likely to develop substance 
abuse and mood disturbances in adulthood (Mattson et al., 2011). Fetal 
exposure of ethanol can predispose CNS to increased neurodegeneration 
and altered synaptic plasticity that are concomitant with cognitive and 
behavioral deficits (Patten et al., 2014; Ke et al., 2011). 
Multiple mechanisms have been proposed for ethanol-induced neu-
rodegeneration; oxidative stress and neuroinflammation are regarded as 
the important ones (Lucas et al., 2006; Qin et al., 2008; Qin and Crews, 
2012; Crews and Nixon, 2009). Ethanol can cross the blood-brain barrier 
(BBB) and consequently activates nuclear factor kappa-light-chain- 
enhancer of activated B cells (NF-κβ)-mediated inflammatory response 
(Crews and Vetreno, 2016). Inflammatory cytokines or substances such 
as high mobility group box 1 (HMGB1) and damage-associated molec-
ular patterns (DAMPs) are released from microglial cells to activate toll- 
like receptors (TLRs) and receptor for advanced glycation end products 
(RAGE) that, in turn, further promote NF-κβ mediated inflammatory 
response (Crews and Vetreno, 2016). Moreover, ethanol can induce 
inflammation in the liver and cause a systemic inflammation; the 
induced inflammatory cytokines, e.g., tumor necrosis factor-alpha 
(TNFα), can cross BBB through receptor-mediated transportation and 
contribute to the existing inflammation in the brain (Crews and Vetreno, 
2016; Ferrier et al., 2006). Ethanol exposure can also produce oxidative 
stress, which is devastating. Oxidative stress may cause neuronal death 
directly or interact with the inflammatory pathway to potentiate the 
harmful effects of neuroinflammation (Morgan and Liu, 2011; Kratsov-
nik et al., 2005). It has also been reported that oxidative stress can 
inhibit neurogenesis and thereby indirectly contributes to neuronal loss 
(Crews and Vetreno, 2016). 
Endoplasmic reticulum (ER) regulates protein folding; only properly 
folded proteins can pass through quality control surveillance and shuttle 
to the Golgi compartment. Misfolded proteins are retained in ER through 
interactions with chaperones and eventually targeted for degradation 
either by the ubiquitin-proteasome system (UPS) or by the autophagy- 
lysosome system. The overload of unfolded or misfolded protein in ER 
resulted from various conditions, such as pathogen infection, nutrient 
deprivation, inflammation, alterations in ER luminal Ca2+ or redox 
status, and toxic chemicals can cause ER stress (Ron, 2002). ER stress 
activates an unfolded protein response (UPR) to eliminate unfolded or 
misfolded proteins in the ER. The UPR is regulated through three ER- 
localized transmembrane proteins, Inositol-requiring kinase (IRE1), 
protein kinase RNA-like endoplasmic reticulum kinase (PERK), and 
activating transcription factor 6 (ATF6) (Marciniak and Ron, 2006). 
When ER stress is excessively activated, and the cellular function cannot 
be restored, it leads to cell death (Hetz and Saxena, 2017). Accumulation 
of misfolded protein is a sharing characteristic of many neurodegener-
ative diseases such as Parkinson’s disease, Alzheimer’s disease, Hun-
tington’s disease, and Amyotrophic Lateral Sclerosis (ALS) (Hetz and 
Saxena, 2017; Aguzzi and O’Connor, 2010). ER stress has been impli-
cated as one of the underlying mechanisms for these neurodegenerative 
diseases. With a variety of preclinical models, targeting UPR through 
pharmacological and genetic approaches in these diseases generated 
profound effects on the outcomes of these diseases (Hetz and Saxena, 
2017). Ethanol-induced ER stress is linked with multiple organ injuries; 
ER stress is found in acute pancreatitis (Kubisch et al., 2006; Pandol 
et al., 2010; Lugea et al., 2011), ethanol-induced liver disease (ALD) (Ji 
and Kaplowitz, 2006; Ji et al., 2011; Dara et al., 2011; Ji et al., 2005), 
and the myocardium of ethanol-fed mice (Li and Ren, 2008). ER stress is 
induced by ethanol exposure in both adult and developing mouse brain. 
Moreover, blockage of ER stress with pharmacological inhibitors re-
duces ethanol-induced neurodegeneration, indicating that ER stress 
contributes to ethanol-induced neurodegeneration (Ke et al., 2011; 
Wang et al., 2018). 
MANF, also recognized as arginine-rich mutated in early stages of 
tumor (ARMET), was identified in a ventral mesencephalic astrocyte cell 
line 1 in search of astrocyte-derived neurotrophic factor (Petrova et al., 
2003). MANF is widely expressed in the cerebral cortex, hippocampus, 
and cerebellum and can also be detected in the liver, kidney, and testes 
(Lindholm et al., 2008). The crystal structure of mammalian MANF has 
revealed that MANF contains several motifs: a saposin-like domain in 
the amino-terminal, an SAP-like domain in the carboxy-terminal and a 
C-X-X-C motif. The saposin-like domain can interact with lipid and 
membrane, thereby linking MANF to the ER membrane. The SAP-like 
domain shares high homology with the SAP domain in Ku70 and has 
been reported to interact with proapoptotic proteins such as Bad and Bax 
to inhibit their function. The C-X-X-C motif is commonly found in pro-
tein disulfide isomerase, mediating the formation of disulfide bonds 
(Hellman et al., 2011; Hoseki et al., 2010). MANF is involved in neural 
development, such as neurite outgrowth and neuronal migration (Tseng 
et al., 2017). MANF has been found to have trophic effects on embryonic 
dopaminergic neurons both in vitro and in vivo (Petrova et al., 2003; 
Voutilainen et al., 2009; Lindholm and Saarma, 2010). Neves et al. 
shows that MANF is induced in innate immune cells during retina injury; 
the induced MANF is involved in the alternative activation of microglial 
cells, which is essential for retinal repair and regeneration (Neves et al., 
2016). It has also been shown that MANF can cause insulin resistance in 
the neurons of the hypothalamus, thereby increasing food intake and 
causing hyperphagia phenotype in mice (Yang et al., 2017). Meantime, 
MANF has been found to respond to ER stress and identified as a protein 
upregulated by UPR (Apostolou et al., 2008). It is upregulated in 
myocardial infarction and brain diseases such as cerebral epilepsy, and 
ischemia wherein ER stress is a sharing characteristic (Lindholm et al., 
2008; Yu et al., 2010; Tadimalla et al., 2008). 
We demonstrated that MANF was induced in the developing mouse 
brain after ethanol exposure (Li et al., 2019; Ke et al., 2011). We hy-
pothesized that MANF was associated with ER stress regulation and 
protective against ethanol-induced neurodegeneration. In the present 
study, we investigated the role of MANF in ER stress and its association 
with ethanol-induced neuronal damage using a well-established third- 
trimester equivalent mouse model. 
2. Materials and methods 
2.1. Reagents and antibodies 
Reagents for blood ethanol levels were purchased from Analox In-
struments (London, UK). ATF6 was purchased from Life Span Bio-
sciences (Seattle, WA). Cleaved caspase-3 was from Cell Signaling 
Technology (Danvers, MA). GRP78 antibody was from Novus Biologicals 
(Littleton, CO). X-box binding protein-1s (XBP1s) antibody was from 
BioLegend (San Diego, CA). MANF antibody was from Abcam (Cam-
bridge, MA). CCAAT/enhancer-binding protein homologous protein 
(CHOP) antibody was from Thermo Fisher Scientific (Rockford, IL). 
HRP-conjugated anti-rabbit and anti-mouse secondary antibodies were 
from GE Healthcare Life Sciences (Piscataway, NJ). Mounting media 
containing 4′, 6-diamidino-2-phenylindole (DAPI) was from Vector 
Laboratories (Burlingame, CA). Alexa-488 conjugated anti-rabbit and 
Alexa-594 conjugated anti-mouse antibodies were from Life Technolo-
gies (Grand Island, NY). Ketamine/xylazine was from Butler Schein 
Animal Health (Dublin, OH). Other chemicals and reagents were pur-
chased either from Sigma-Aldrich or Life Technologies (Frederick, MD). 
2.2. Animal model 
2.2.1. Central nervous system specific Manf knockout 
Embryonic stem cell clone EPD0162_3_D06 (Manf tm1a(KOMP)Wtsi) as 
illustrated in Fig. 1 was generated by the Wellcome Sanger Institute and 
injected into blastocyst by the Knockout Mouse Project (KOMP) 
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Repository and the Mouse Biology Program at the University of Cali-
fornia (UC) Davis. The generated chimeric mice were then bred with 
C57BL/6 N mates. Then via UC Davis Mouse Biology Program, MANF 
mice were crossed with an FLP recombinase line for in vivo recombi-
nation to convert to the conditional (floxed) allele. The FLP recombinase 
line was obtained from the MMRRC: C57BL/6-Tg(CAG-Flpo)1Afst/ 
Mmucd, 032247-UCD. Two generations of breeding were performed to 
ensure excision in the germ cells and remove the FLP transgene. They 
also bred to homozygosity at our request. Nestin-Cre+/− transgenic mice 
(B6.Cg-Tg(Nes-Cre)1Kln/J) were obtained from Jackson Laboratory. 
Manf flox/flox mice were first crossed with Nestin-Cre+/− mice to generate 
Manf flox/+::Nestin-Cre+/− mice. Then the offspring were crossed with 
Manf flox/flox mice to generate Manf flox/flox::Nestin-Cre+/− mice in which 
Manf was specifically knocked out in the central nervous system. For 
genotyping, mice tail genomic DNA was extracted using Fast Tissue/Tail 
PCR Genotyping Kit (EZ BioResearch) according to the manufacturer’s 
instructions. Primers used for genotyping are as follows: Manf-f2, 
GAGATGGCGCAACGCAATTAATG; Manf-r2, CCATGGTGATGCTG-
TAACTGTCACG; Manf-r1, TGCTCAGCTGCAGAGTTAGAGTTCC; Manf- 
f1, TGAAGCAAGAGGCAAAGAGAATCGG. Cre-F, GGTTCGCAA-
GAACCTGATGG; Cre-R, GCCTTCTCTACACCTGCGG. Touch-Down PCR 
protocol was used for the reactions. For the first 10 cycles which 
annealed at 65 ◦C decreasing in temperature by 1 ◦C per cycle and an 
additional 30 cycles annealed at 55 ◦C. The amplifications were per-
formed in 12 μl volume, and the PCR cycles were 94 ◦C for 5 min, 94 ◦C 
for 15 s, annealing for 30 s, 72 ◦C for 40 s and final extension 72 ◦C for 5 
min. The length of amplified bands for Manf+/+, Manf flox/flox (CTL), and 
conditional Manf flox/flox::Cre+/− (cKO) targeted locus are listed as in 
Fig. 1. 
2.2.2. Ethanol- and TM-induced neurodegeneration in mice 
All experimental procedures were approved by the Institutional 
Animal Care and Use Committee (IACUC) at the University of Kentucky 
(#2008–0401) and performed following regulations for the Care and 
Use of Laboratory Animals set forth by the National Institutes of Health 
(NIH) Guide. Two animal models were used in this study to investigate 
the effects of MANF on ER stress-induced neuronal damage: ethanol- 
induced neurodegeneration and TM-induced neurodegeneration. In 
ethanol-induced neurodegeneration, postnatal day (PD)7 pups (CTL and 
cKO) were randomly assigned to two groups: control and ethanol group; 
they were injected with PBS or ethanol (1.5 g/kg, 20% solution in PBS) 
subcutaneously twice at a two-hour interval. Neuronal apoptosis and ER 
stress were assessed 8 h after the first injection. In TM-induced neuro-
degeneration, PD7 pups (CTL and cKO) were injected with 150 mM 
dextrose (Mock treatment) or TM (3 mg/kg, 30% solution in dextrose) 
subcutaneously once. Neuronal apoptosis and ER stress were assessed 
24 h after the injection. For inhibition of ER stress with sodium phe-
nylbutyrate (4-PBA), PD6 pups (CTL and cKO) were injected with 4-PBA 
or PBS subcutaneously twice at a dose of 100 mg/kg 24 h and 2 h in 
advance and then subjected to ethanol or TM treatment following the 
same procedure as above. Neuronal apoptosis and ER stress in the brain 
from the CTL group and cKO mice were evaluated with immunoblotting 
and immunohistochemistry of ER stress markers and apoptotic markers 
as well as TUNEL assay. The experimenters were blinded to group 
assignment (control or experimental group). 
2.3. Measurement of blood ethanol concentration (BEC) 
One hour after ethanol injection, blood samples were collected from 
the tail vein. The blood was centrifuged, and 10 ul of the plasma was 
Fig. 1. Schematic illustration of CNS-specific Manf knockout. Schematic representation of Manf+/+ wild-type, Manfflox/flox, and Manf flox/flox::Cre+/− targeted locus. 
E: exon. Arrowheads indicate priming sites used in genotyping by PCR. 
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used to measure BEC using an Analox AM 1 analyzer (Lunenburg, MA) as 
previously described (Xu et al., 2016). 
2.4. Immunoblotting 
Brain tissues were collected, and proteins were extracted. Around 
30–50 μg of extracted protein was used in immunoblots to examine the 
levels of ER stress markers (GRP78, CHOP, XBP1s, and ATF6), MANF, 
and apoptotic markers (cleaved caspase-3). The nitrocellulose mem-
branes were first probed with specific primary antibodies overnight at 
4 ◦C. After washing with phosphate-buffered saline (PBS) containing 
0.05% Tween-20 three times, the membranes were incubated with anti- 
rabbit or anti-mouse secondary antibodies (horseradish peroxidase- 
conjugated) for 1 h at room temperature. Protein-specific signals were 
then detected with enhanced chemiluminescence substrate (GE 
Healthcare, Chalfont, Buckinghamshire, UK) using a Chemi™Doc im-
aging system (Bio-Rad 215 Laboratories, Hercules, CA) and then quan-
tified with the software of Image lab 5.2 (Bio-Rad Laboratories, 
Hercules, CA). 
2.5. Immunohistochemistry and immunofluorescence 
Mouse brains were dissected and processed for immunofluorescence 
(IF) or immunohistochemistry (IHC) staining as previously described 
(Chen et al., 2012; Ke et al., 2011). In brief, brain tissues were fixed with 
4% paraformaldehyde (PFA) overnight and then transferred to 30% 
sucrose to dehydrate. Next, the brain tissues were sectioned sagittally at 
a thickness of 15 μm and then mounted onto superfrost/plus slides. The 
slides mounted with brain sections were incubated with 0.3% H2O2 in 
methanol, permeabilized with 1% Triton X-100 and blocked with 1% 
BSA at room temperature. After that, these slides were immunostained 
with the following individual or combined primary antibodies: MANF 
(1:200), cleaved caspase 3 (1:200), CHOP (1:50), or NeuN (1:200). The 
slides were then incubated with anti-rabbit or anti-mouse secondary 
antibody conjugated to Alexa Fluor 488 or biotin. The immunolabelings 
were visualized using nickel-enhanced 3,3’-Diaminobenzidine (DAB) or 
Alexa Fluor 488 (green) and imaged with an inverted fluorescent mi-
croscope (IX81, Olympus). 
2.6. TUNEL assay 
Brain sections were prepared and mounted to slides as described 
above and then subjected to TUNEL analysis according to the protocol 
from manufacture (Roche, Cat No. 11684817910). In brief, the brain 
sections/slides were incubated with a blocking solution (3% H2O2 in 
methanol) for 10 min and then incubated with permeabilization solution 
(0.1% Triton X-100 and 0.1% sodium citrate) for 2 min. Next, these 
sections/slides were incubated with TUNEL reaction mixture at 37 ◦C in 
a humidified atmosphere in the dark for 60 min. A brain section incu-
bated with labeling solution was used as the negative control and a brain 
section digested with DNase I and incubated with TUNEL reaction 
mixture as the positive control. The slides were then mounted with 
DAPI-containing medium and imaged with an inverted fluorescent mi-
croscope (IX81, Olympus). 
2.7. RNA isolation and real-time PCR 
Total RNA from the brain or liver was extracted using Trizol Reagent 
(Life Technologies) and treated with RNA-free DNAase I to remove 
remnant DNA as described previously (Kim et al., 2014). cDNA used for 
gene detection was synthesized as described previously using Super-
Script III reverse transcriptase and random primers (Kim et al., 2014). 
The primers used for this study were purchased from Fisher Scientific as 
below: UBXN6, Mm01272178; GRP78, Mm00517691; UBE2J2, 
Mm01263784; PDIA6, Mm01270904; ERLEC1, Mm00458735; HYOU1, 
Mm00491279; Manf, Mm00512511; 18 s rRNA, Mm03928990. The 
relative expression was normalized to internal control (18 s rRNA) using 
cycle time (Ct). The relative difference between the control and treat-
ment group was expressed and calculated as relative increases using 2- 
ΔΔCt and setting control as 1. 
2.8. RNA sequencing and data analysis 
Total RNA was isolated from brain tissues of two groups of PD7 mice 
with each group having three samples: CTL group and cKO group. 
Therefore, six RNA samples were submitted to the University of Ken-
tucky Genomics Core Laboratory for the whole transcriptome 
sequencing. Libraries were assembled using the KAPA RNA HyperPrep 
Kits with RiboErase (HMR) for Illumina Platforms and indexed with 
KAPA Single-Indexed Adapter Kit (KAPA Biosystems). Indexed libraries 
were pooled in equimolar concentrations and the denatured pool diluted 
to a final concentration of 10 pM. This pool was spiked with 5% PhiX 
Control library. The combined pool was clustered on board using a 
HiSeq SR Rapid Cluster Kit v2 (Illumina) and sequenced on an Illumina 
HiSeq 2500 Sequencing system using a HiSeq Rapid SBS Kit v2 
(Illumina). 
The transcriptome of each sample was analyzed with ensemble 
GRCm38 Mouse Transcriptome as reference. Transcript abundance was 
calculated with RNA-Seq by Expectation-Maximization (RSEM) analysis 
(Li and Dewey, 2011) and differentially expressed genes were calculated 
using EBSeq (Leng et al., 2015). A false detection rate (FDR) analysis 
with a 0.05 threshold was performed. The lists of DE genes were sub-
mitted to Enrichr for gene ontology enrichment (GOEA) analysis 
(Kuleshov et al., 2016). 
2.9. Statistics 
The data were expressed as mean ± SEM, and statistical significance 
was determined using Student Unpaired t-test, one-way ANOVA, or two- 
way ANOVA followed by Bonferroni Multiple Comparison test (Graph-
Pad Prism version 7). A p-value of less than 0.05 was considered sta-
tistically significant. 
3. Results 
3.1. Characterization of the CNS-specific Manf knockout mouse model 
CNS-Manf-KO (cKO) mice exhibited a CNS-specific Manf knockout 
(Fig. 2A). The expression level of MANF was dramatically decreased 
across the entire mouse brain compared with that in control (CTL) lit-
termates (Manf flox/flox mice) (Fig. 2A and B). We also measured the body 
weight and brain weight and calculated the ratio of brain weight to body 
weight in cKO mice and CTL littermates. In brevity, the weight of cKO 
mouse brain and body was less than that in the CTL group (Fig. 2C and 
D). However, the ratio of brain weight to body weight between these two 
groups showed no significant difference (Fig. 2E). It is noteworthy that 
the difference in body weight can extend to the adult stage (Fig. 2F). We 
thought the decrease in body weight and brain weight might be due to 
the involvement of MANF in neuronal development and energy meta-
bolism. Consistent with the previous report, we did not observe signif-
icant behavioral changes in cKO mice (Pakarinen et al., 2020). However, 
some Manf KO dams did not take care of their pups as well as wild-type 
dams, and foster dams were sometimes necessary. 
3.2. MANF deficiency alters ER-related RNA signature and causes ER 
stress in the developing mouse brain 
To investigate whether MANF is involved in ER stress regulation, we 
conducted RNA-Seq and examined RNA expression profile in ER using 
brain samples from the CTL and cKO groups. A total of 2212 differen-
tially expressed (DE) genes were detected (not shown here); however, 
only 933 had identified identifiers (not shown here). The 933 genes were 
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associated with many signaling pathways and a total of 18 DE genes 
were identified to be associated with protein assessing in the endo-
plasmic reticulum (Table 1). Among these 18 genes, most of them were 
upregulated by Manf cKO; three genes (EDEM3, UBE2J2, and UBXN6) 
were downregulated in the brain of Manf cKO mice (Table 1 and 
Fig. 3A). In term of gene function, eight genes (PDIA3, GRP78, PDIA6, 
DDOST, PDIA4, HSP90B1, DNAJC3, and HYOU1) were associated with 
protein chaperoning function or protein folding, seven genes (EDEM3, 
UBE2J2, ERLEC1, SELENOS, UGGT1, UBXN6, and ATF4) were associ-
ated with protein quality control or ER-associated degradation, whereas 
three genes (RRBP1, SEC61A1, and SEC24D) were mainly involved in 
protein trafficking or secretory pathways. We verified those DE genes 
Fig. 2. Characterization of the CNS-specific Manf knockout mouse model. A. Representative immunoblots of MANF in cerebral cortex (CC), cerebellum (CB), 
subcortical structure (SC), liver and heart in the control (CTL) and Manf conditional knockout (cKO) mice. The data was expressed as mean ± SEM. n = 3–5 per 
group, ***p < 0.001 vs. CTL. B. Representative immunohistochemical staining of MANF in CC, HP (hippocampus) and CB sections of PD7 pups from the CTL and cKO 
groups. Scale bar: 20 um. n = 3–5 animals per group, ***p < 0.001 vs. CTL. C–F. Measurement and calculation of brain weight (C) and body weight (D and F) and the 
ratio of brain weight to body weight (E) in the CTL and cKO mice. PD: postnatal day. PM: postnatal month. n = 8–11 per group, **p < 0.01 or ***p < 0.001 vs. CTL. 
Table 1 
Differentially expressed genes related to protein processing in the ER from RNA-Seq.  
Gene symbols Transcripts per million (TPM) Fold change* 
CTL1 CTL2 CTL3 cKO1 cKO2 cKO3 
EDEM3 10.59 0 0 0 0.03 0 − 353 
PDIA3 178.25 194.95 198.1 236.47 229.3 245.79 +1.25 
GRP78 190.45 210.63 200.87 325.24 321.53 373.94 +1.70 
RRBP1 0 0 0 5.73 0 0 +3549 
UBE2J2 3.62 2.7 0.56 0 0 0 − 2870 
PDIA6 106.21 125.87 111.92 168.65 177.94 175.76 +1.52 
DDOST 74.59 78.86 81.03 100.56 109.77 114.31 +1.38 
PDIA4 64.16 67.02 72.67 88.98 85.02 91.26 +1.30 
HSP90B1 281.12 335.28 308.45 463.05 428.79 472.81 +1.48 
DNAJC3 27.04 32.01 28.88 45.9 34.96 42.65 +1.40 
SEC61A1 77.17 81.16 81.32 96.02 94.07 105.29 +1.23 
ERLEC1 6.58 11.19 10.87 14.79 14.02 16.97 +1.60 
SELENOS 32.21 39.69 36.44 54.88 50.98 45.98 +1.40 
HYOU1 0 0 0 10.12 8.6 12.97 +17,439 
SEC24D 10.82 15.53 15.35 19.93 19.17 19.79 +1.41 
UGGT1 14.51 16.23 16.71 20.55 19.63 24.6 +1.37 
UBXN6 8.03 6.79 4.52 0 0 0 − 3004 
ATF4 105.87 134.57 107.86 157 149.97 156.83 +1.33 
*, − and +indicate down- and up-regulation, respectively (cKO vs CTL). 
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that showed more than 1.5 folds change between the CTL group and the 
cKO group by RT-qPCR (Fig. 3B–H). As expected, Manf mRNA level was 
significantly reduced in the brain of Manf cKO mice (Fig. 3B). Overall, 
the results were consistent with our RNA-Seq data, reflecting the same 
change of those targets in the Manf cKO group (Fig. 3C, D, G and H). 
However, we did find that the expression level of GRP78 and ERLEC1 
did not differ significantly between the control group and Manf cKO 
group (Fig. 3E and F). In summary, the RNA-Seq results further 
demonstrated that MANF acted as an ER stress-buffering agent and that 
MANF deficiency caused dysregulation of genes associated with protein 
folding. 
There was no significant induction of neuronal apoptosis (Fig. 4A 
and B) in the cKO mouse brain. However, MANF deficiency caused a 
modest increase in ER stress manifested by the upregulation of GRP78 
and ATF6 (Fig. 4C). This finding is consistent with the recent report 
showing that MANF ablation causes prolonged activation of the UPR 
with the absence of neurodegeneration in the mouse brain (Pakarinen 
et al., 2020). 
3.3. MANF deficiency exacerbates ethanol- and TM-induced neuronal 
apoptosis in the developing brain 
To investigate the effects of MANF deficiency on ethanol-induced 
neuronal apoptosis, a modified neonatal ethanol exposure paradigm 
was employed (Olney et al., 2002). This ethanol exposure paradigm 
resulted in a BEC of 185 ± 10 mg/dl. The BEC was similar between CTL 
and cKO mice (data not shown). While ethanol exposure alone resulted 
in moderate neuronal apoptosis in the developing mouse brain, we 
found that MANF deficiency dramatically promoted ethanol neurotox-
icity (Fig. 5A and 2B). Co-labelling with TUNEL and NeuN (a neuron 
marker) revealed that almost all of the apoptotic cells were neurons 
(Fig. 5C). The apoptotic neurons, in general, spread across the entire 
brain, but some regions (e.g., frontal cortex, cerebellum, thalamus, and 
hippocampus), indeed, showed more vulnerability. To investigate 
whether the effects of MANF are ubiquitous to all ER stress- 
characterized neurodegenerative diseases, we treated the mice with a 
general ER stress inducer, TM (3 mg/kg, 30% solution in dextrose) 
following the same procedure except that the treatment duration was 24 
h. The results presented a similar pattern showing that MANF deficiency 
exacerbated TM-induced neuronal apoptosis, especially in the frontal 
cortex, cerebellum, and hippocampus (Fig. 5D and E). Taken together, 
these results suggest that MANF is neuroprotective against ethanol- 
induced neuronal apoptosis and that the neuroprotective effects of 
MANF likely apply to ER stress-characterized neurodegenerative 
diseases. 
Fig. 3. Verification of DE genes that are associated with protein processing in ER. A. Heat map representing color-coded DE genes that are associated with protein 
processing in ER. B–H. Verification of DE genes that are associated with protein processing in ER by RT-qPCR. n = 3, *p < 0.05 or **p < 0.01 vs. CTL. 
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Fig. 4. MANF deficiency causes ER stress in the developing mouse brain. A. Representative immunoblots of cleaved caspase 3 (Cl. Casp 3) in cerebral cortex (CC), 
cerebellum (CB) and subcortical structure (SC) in the CTL and cKO mice. n = 3–5. B. Representative immunohistochemical staining of Cl. Casp 3 in CC, HP (hip-
pocampus) and CB sections of PD7 pups from the CTL and cKO groups. Scale bar: 20 um. n = 3–5. C. Representative immunoblots of ER stress markers (GRP78 and 
ATF6) in cerebral cortex (CC), cerebellum (CB) and subcortical structure (SC) in the control (CTL) and Manf conditional knockout (cKO) mice. n = 3–5, *p < 0.05 
vs. CTL. 
Fig. 5. MANF deficiency exacerbates ethanol- and TM-induced neuronal apoptosis. A. Representative immunoblots of MANF and cleaved caspase 3 (Cl.Casp3) in 
cerebral cortex (CC) and cerebellum (CB) of PD7 pups from the control (CTL/PBS and CTL/EtOH) and cKO (cKO/EtOH) groups. n = 3–5, *p < 0.05 or **p < 0.01 vs. 
CTL/PBS. #p < 0.05 or ##p < 0.01 vs. CTL/EtOH. B. Representative immunohistochemical staining of Cl.Casp3 in CC, HP (hippocampus), and CB sections of PD7 
pups from the control (CTL/EtOH) and cKO (cKO/EtOH) groups. Scale bar: 20 um. n = 3–5, *p < 0.05 vs. CTL/EtOH. C. Representative images of co-labeling with 
TUNEL (green) and NeuN (red) in CC, CA1, and CB sections of PD7 pups from the cKO group. Scale bar: 20um. D. Representative immunoblots of MANF and Cl. 
Casp3 in cerebral cortex (CC) and cerebellum (CB) of PD7 pups from the control (CTL/mock and CTL/TM) and cKO (cKO/TM) groups. n = 3–5, *p < 0.05 vs. CTL/ 
mock. #p < 0.05, ##p < 0.01 or ###p < 0.001 vs. CTL/TM. E. Representative staining of Cl.Casp3 in CC, CA1, and CB sections of PD7 pups from the control (CTL/ 
TM) and cKO (cKO/TM) groups. Scale bar: 20 um. n = 3–5, *p < 0.05 or ***p < 0.001 vs. CTL/TM. 
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3.4. MANF deficiency promotes ethanol- and TM-induced ER stress in the 
developing mouse brain 
To determine whether the resulting increase of neuronal apoptosis 
was attributed to ER stress over-activation, we examined ER stress levels 
in the entire mouse brain and compared that level between CTL pups 
and cKO pups following the same treatment and procedure. Consistent 
with our published results, we found a moderate increase in ER stress 
due to ethanol or TM exposure alone (Fig. 6A and D). However, we 
found MANF deficiency potentiated ethanol- or TM-induced ER stress, 
causing a further dramatic enhancement of ER stress in the cerebral 
cortex, cerebellum, and hippocampus of the mouse brain (Fig. 6A–E). 
This data suggests that MANF may function as an ER stress-buffering 
agent, and the deficiency of MANF exacerbates ethanol- or TM- 
induced ER stress. Notably, while ethanol- or TM-induced apoptosis is 
more confined to specific brain regions, e.g., cerebellum, cerebral cor-
tex, or hippocampus, the induction of ER stress is more wide-spread. 
3.5. Blocking ER stress abrogates MANF deficiency-induced exacerbation 
of neuronal apoptosis 
Co-labeling with TUNEL and CHOP (an ER stress marker) revealed 
that most apoptotic neurons expressed a high level of CHOP, indicating 
that neuronal apoptosis might be associated with the induction of ER 
stress (Fig. 6C). To determine whether the increase of neuronal 
apoptosis due to MANF deficiency was attributed to the exacerbation of 
ER stress, we have employed a pharmacological inhibitor of ER stress–4- 
PBA. 4-PBA is a chemical chaperone that has been widely used to pre-
vent ER stress in the liver, adipose tissue, and brain. 4-PBA did not 
significantly change BEC (data not shown). In our animal models, pre-
treatment with 4-PBA can block ethanol- and TM- induced ER stress both 
in the CTL group and cKO mice (Fig. 7A and C). Meanwhile, ethanol- and 
TM- induced neuronal apoptosis was also abolished by the employment 
of 4-PBA (Fig. 7A–D). Collectively, this data suggests that the over-
activation of ER stress is accountable for the exacerbation of neuronal 
apoptosis. 
4. Discussion 
We demonstrate that MANF is neuroprotective against ethanol- 
induced neurodegeneration through ameliorating ER stress and the 
neuroprotective role of MANF is likely applied to other ER stress- 
characterized neurodegenerative diseases. Moreover, the results from 
a whole transcriptome RNA sequencing on brain samples from Manf cKO 
mice and control mice provide evidence about the involvement of MANF 
in ER stress regulation and shed light on the potential targets that 
mediate the ER stress-buffering capacity of MANF in ethanol-induced 
neurodegeneration. 
A third-trimester equivalent mouse model is used in our study to 
model developmental exposure to ethanol. Due to a developmental 
timing shift between humans and rodents, the developmental period of 
the rodent brain in PD1-10 is equivalent to the third trimester in humans 
when brain growth spurt occurs (Semple et al., 2013). The original 
model was established by Olney’s group and was widely used to induce 
neurodegeneration in infant mice (Olney et al., 2002). In addition, we 
choose to examine the impact of MANF on ethanol- and TM-induced ER 
stress and neuronal death in the developing mouse brain for the 
following two reasons. First, ER stress is responsive to ethanol exposure 
Fig. 6. MANF deficiency exacerbates ethanol- and TM-induced ER stress. A. Representative immunoblots of ER stress markers (GRP78, CHOP, XBP1s and ATF6) in 
the whole brains of PD7 pups from control (CTL/PBS and CTL/EtOH) and cKO (cKO/EtOH) groups. n = 3–5, *p < 0.05 or **p < 0.01 vs. CTL/PBS. #p < 0.05 vs. 
CTL/EtOH. B. Representative immunohistochemical staining of CHOP (red) and DAPI (blue) in CC, CA1, and CB sections of PD7 pups from control (CTL/EtOH) and 
cKO (KO/EtOH) groups. Scale bar: 20um. n = 3–5, *p < 0.05 or **p < 0.01 vs. CTL/EtOH. C. Representative images of co-labeling with TUNEL (green) and CHOP 
(red) in CC, CA1, and CB sections of PD7 pups from the cKO/EtOH group. Scale bar: 20um. D. Representative immunoblots of ER stress markers (GRP78, CHOP, 
XBP1s and ATF6) in the entire brains of PD7 pups from control (CTL/mock and CTL/TM) and cKO (cKO/TM) groups. n = 3–5, *p < 0.05 vs. CTL/mock. #p < 0.05 or 
##p < 0.01 vs. CTL/TM. E. Representative staining of CHOP (brown) and Hematoxylin (blue) in CC, CA1, and CB sections of PD7 pups from control CTL/TM and 
cKO/TM groups. Scale bar: 20um. n = 3–5, *p < 0.05 or **p < 0.01 vs. CTL/TM. 
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in the developing brain to a greater extent than in the adult brain (Ke 
et al., 2011; Wang et al., 2018). Second, the expression level of MANF 
varies over time during brain development; it has its highest expression 
during the developmental stage and declines afterward (Wang et al., 
2014). We believe that the beneficial effects of MANF on ER stress and 
ethanol- and TM-induced neurodegeneration is more predominant in the 
developing brain than in the adult brain. 
MANF ablation alone does not result in neurodegeneration, but 
causes a modest activation of UPR. This finding is consistent with the 
recently published results, suggesting that MANF deficiency alone is not 
sufficient to elicit the pathological phenotype-neurodegeneration (Pak-
arinen et al., 2020). Next, we investigate the effects of MANF on ER 
stress and neurodegeneration in pathological conditions: ethanol- and 
TM-induced neurodegeneration. MANF deficiency exacerbates ethanol- 
and TM-induced ER stress and neurodegeneration. The results suggest 
that the beneficial effects of MANF may be ubiquitous to all ER stress- 
characterized neurodegenerative diseases. Nevertheless, brain regions 
that are sensitive to these two respective inducements vary. Neuronal 
apoptosis in the TM-induced neurodegenerative model mainly occurs in 
the cerebellum, whereas the apoptotic cells in the ethanol-induced 
neurodegenerative model are wide-spread, with some regions appear-
ing more vulnerable, such as the frontal cortex, cerebellum, thalamus, 
and hippocampus. 
MANF expression is generally regulated by the transcriptional acti-
vation of ATF6 and XBP1s through the binding of the ER stress response 
element II (ERSE-II) and ERSE-I located in its promotor region, respec-
tively (Oh-Hashi, Hirata, & Kiuchi, 2013; D. Wang et al., 2018; Tadi-
malla et al., 2008). Our result shows that ethanol- and TM- exposure 
caused a significant upregulation of both ATF6 and XBP1s proteins 
(Figs. 6 and 7), suggesting that ethanol may increase MANF expression 
by targeting ATF6 and XBP1s. Although MANF is an ER-resident protein, 
secretory MANF has been found in circulation and interstitial tissue 
(Lindholm and Saarma, 2010). ER stress can stimulate a robust secretion 
of MANF (Henderson et al., 2013). Both intracellular and extracellular 
MANF exhibits protective effects in different disease models. Injection of 
recombinant MANF protein into brain regions were reported to alleviate 
ER stress and protect neurons in cerebral ischemia and animal models of 
Parkinson’s disease (Voutilainen et al., 2009; Yang et al., 2017). In vitro 
studies using cultured neuronal cells have also demenstrated a protec-
tive effect of extracellular MANF in Alzheimer’s disease and Parkinson’s 
disease models (Liu et al., 2018; Xu et al., 2016). Our results indicate 
that MANF functions as an ER stress-buffering agent to ameliorate ER 
stress and as a result, MANF deficiency causes a deterioration of ER 
stress. While the exact mechanisms that underlie the buffering effects of 
MANF on ER stress remain unclear, several mechanisms have been 
proposed. A study recently reported that the SAP domain of MANF in-
teracts with BiP, antagonizing BiP-mediated nucleotide change, and 
thereby stabilizes BiP-client complexes to facilitate protein folding (Yan 
et al., 2019). Second, MANF contains a C-XX-C motif and has been re-
ported to be involved in disulfide bond formation, a critical step in 
protein folding in the ER (Hoseki et al., 2010). Alternatively, one group 
demonstrated that MANF is a structurally unique redox-sensitive chap-
erone that can restore protein folding in the ischemic heart (Arrieta 
et al., 2017). 
Our RNA sequencing data confirm the functionality of MANF in ER 
stress regulation. In addition to the ER stress markers that are confirmed 
by immunoblots, it has identified a number of targets that are ER- 
resident protein responsible for the folding and trafficking of newly 
synthesized protein. These target proteins carry on a series of functions 
ranging from protein chaperoning, protein disulfide isomerization to 
ER-associated protein degradation. It should be noted that these proteins 
could be direct targets of MANF or indirect targets that are indicative of 
the deterioration of ER stress. Most of the upregulated transcripts are 
ER-resident chaperones or protein disulfides (PDIs) that can improve an 
adaptation to ER stress, whereas most of the downregulated transcripts 
(UBE2J2 and UBXN6) are ubiquitin-conjugating enzymes that are 
involved in proteasomal degradation (Nagahama et al., 2009; Wang 
et al., 2009). We speculate that MANF deficiency may disrupt the 
ubiquitination system and consequently causes ER stress manifested by 
an abrupt increase of ER stress-related transcripts. Further experiments 
Fig. 7. Blocking ER stress abrogates the deleterious effects of MANF deficiency on ethanol- and TM-induced neuronal apoptosis. A. Representative immunoblots of 
ER stress markers and Cl. Casp 3 in the whole brains of PD7 pups from the control (CTL/EtOH and CTL/EtOH/4-PBA) and cKO (cKO/EtOH and cKO/EtOH/4-PBA) 
groups. n = 3–5, *p < 0.05 or **p < 0.01 vs. corresponding treatment control (CTL/EtOH or cKO/EtOH) groups. #p < 0.05 or ##p < 0.01 vs. CTL/EtOH. B. 
Representative images of TUNEL (green) and DAPI (blue) labeling in CC, CA1, and CB sections of PD7 pups from cKO/EtOH and cKO/EtOH/4-PBA groups. Scale bar: 
20 um. n = 3–5, ***p < 0.001 vs. cKO/EtOH. C. Representative immunoblots of ER stress markers and Cl.Casp3 in the entire brains of PD7 pups from control (CTL/ 
TM and CTL/TM/4-PBA) and cKO (KO/TM and KO/TM/4-PBA) groups. n = 3–5, *p < 0.05 or **p < 0.01 vs. corresponding treatment control (CTL/TM or cKO/TM) 
groups. #p < 0.05 or ##p < 0.01 vs. CTL/TM. D. Representative images of TUNEL (green) and DAPI (blue) labeling in CC, CA1, and CB sections of PD7 pups from 
cKO/TM and cKO/TM/4-PBA groups. Scale bar: 20 um. n = 3–5, **p < 0.01 vs. cKO/TM. 
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are needed to identify their physical and functional connection with 
MANF. 
In summary, we have established a CNS-specifc Manf knockout 
mouse model and provided strong evidence using this model of loss-of- 
function of MANF, that MANF is neuroprotective against ethanol or TM- 
induced neurodegeneration in the developing brain through amelio-
rating ER stress. Additional research would strength the current study. 
First, the direct evidence regarding the effects of gain-of-function of 
MANF on ethanol- or TM-induced ER stress and neurodegeneration 
would further verify the current findings. Second, although MANF is an 
ER-resident protein, it is also a secretory factor, typically in stressful 
conditions (Henderson et al., 2013). A study designed to delineate the 
contribution of intracellular MANF or extracellular MANF on ethanol- 
induced neuroprotection would be worthwhile. Lastly, MANF is 
expressed in both neurons and glial cells (Lindholm et al., 2008). It 
would be interesting to differentiate the contribution of neuron- or 
astrocyte-derived MANF to its protection against ethanol-induced 
neuronal damage. A better understanding of the role of MANF in 
ethanol-induced neurodegeneration may reveal MANF as a critical 
player in ER stress regulation, thereby laying a foundation for targeting 
MANF as a therapeutic approach in the treatment of FASD. 
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